Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine

The country's leading biotechnology company Bharat Biotech has applied to the DGCI (Pharmaceutical Controller General of India) for the Phase III trial of a booster dose of its nasal anti-Covid vaccine. Giving this information on Monday, sources said that this booster dose can be given to those people who have got any of the vaccine either Covaxin or Covishield. As we all know these days the country is currently at risk of a new and more infectious Omicron variant of the corona virus. Cases of infection have started increasing once again in the country and it is feared that by February next year, the third wave of corona pandemic may come in the country. Day by day the cases of the variant of the corona virus are increasing that too in different states. Even to counter it the internati...

Read More